Bouchenaki has 25 years of experience in operational and strategic roles in the pharmaceutical and healthcare sectors. Abdul Latif Jameel’s healthcare arm was founded in 2020. In January 2023, the company announced a new distribution agreement with iSono Health—a medical technology company in the U.S.—to make Abdul Latif Jameel Health the exclusive distributor of iSono Health’s ATUSA scanner in MENA, Africa, South Asia, and Southeast Asia. Bouchenaki was previously the executive director for Africa at Gilead Sciences and has held other roles at GSK and Bristol Myers Squibb.